Tagrisso has become a front-line treatment for solid-tumor, EGFR-drivenlungcancer, but Rohs is looking forward to better blood tests that will help doctors direct the pill to the right patients. A month's supply of Tagrisso costs more than $16,000 if paying straight out-of-pocket, accordin...